Detection of CYP1A1 mRNA levels and CYP1A1 Msp 1 polymorphisms as possible biomarkers of exposure and susceptibility in smokers and non-smokers

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 16, Issue 1, 1996, Pages 65-74

  Rumsby, P C ^a   Yardley Jones, A ^a   Anderson, D ^a   Phillimore, H E ^a   Davies, M J ^a  

^a BIBRA INTERNATIONAL   (United Kingdom)

Author keywords

Environmental exposure; Msp 1 polymorphism; P450; RT PCR; Smoking

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING;

BIOLOGICAL MARKERS; BLOTTING, SOUTHERN; CYTOCHROME P-450 CYP1A1; DISEASE SUSCEPTIBILITY; DNA, COMPLEMENTARY; ENVIRONMENTAL POLLUTANTS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MEROZOITE SURFACE PROTEIN 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN PRECURSORS; PROTOZOAN PROTEINS; RNA, MESSENGER; SMOKING;

EID: 0030036412     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1996)16:1<65::AID-TCM7>3.0.CO;2-E     Document Type: Article

References (27)

1. Omiecinski CJ, Redlich CA, Costa P: Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res 50:4315-4321, 1990.
2. Van den Heuvel JP, Clark GC, Thompson CL, McCoy Z, Miller CR, Lucier GW, Bell DA: CYP1A1 mRNA levels as a human exposure biomarker: Use of quantitative polymerase reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 14:2003-2006, 1993.
3. Van den Heuvel JB, Clark GC, Kohn MC, Tritscher AM, Greenlee WF, Lucier GW, Bell DA: Dioxin-responsive genes: Examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res 54:62-68, 1994.
4. Nebert DW: Role of genetics and drug metabolism in human cancer risk. Mutat Res 247:267-281, 1991.
5. Nebert DW, Petersen DD, Puga A: Human AH locus polymorphism and cancer: Inducibility of CYP1A1 and other genes by combustion products and dioxin. Pharmacogenetics 1:68-78, 1991.
6. Crofts F, Taioll E, Trachman J, Cosma EN, Currie D, Toniolo P, Garte SJ: Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15:2961-2963, 1994.
7. McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, Eggleston JC, Boyd MR, Hines RN: Expression of CYP1A1 gene in patients with lung cancer: Evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82:1333-1339, 1990.
8. Kellerman G, Shaw CR, Luyten-Kellerman M: Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Engl J Med 189:934-937, 1973.
9. Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL: Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analysed in cryopreserved lymphocytes. Cancer Res 42:5030-5037, 1982.
10. 1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. Nucleic Acids Res 13:4503-4520, 1985.
11. Waithe WI, Michaud M, Harper PA, Okey AB, Anderson A: The Ah receptor, cytochrome P450IA1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem Pharmacol 41:85-92, 1991.
12. Spurr NK, Gough AC, Stevenson K, Wolf CR: Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res 15:5901, 1987.
13. 1450 cDNA probe. Cytogenet Cell Genet 46:574-575, 1987.
14. Omenn GC: Future research directions in cancer ecogenetics. Mutat Res 247:283-291, 1991.
15. Idle JR: Is environmental carcinogenesis modulated by host polymorphism? Mutat Res 247:259-266, 1991.
16. Brinkworth MH, Yardley-Jones A, Francis AJ, Hughes JA, Anderson D: A comparison of smokers and non-smokers with respect to oncogene products and cytogenetic parameters. J Occup Med 34:1181-1188, 1992.
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
18. Hayashi S-I, Watanabe J, Nakachi K, Kawajiri K: Genetic linkage of lung cancer-associated Msp-1 polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110:407-411, 1991.
19. Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, Nebert DW: Human CYP1A1 gene: Cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48:720-725, 1991.
20. Hayashi SI, Watanabe J, Nakachi K, Eguchi H, Gotoh O, Kuwajiri K: Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15:801-806, 1994.
21. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporado NE: Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4:242-246, 1994.
22. 1450) gene: Lack of association between the Msp 1 restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1:20-25, 1991.
23. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J: Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263:131-133, 1990.
24. Wedlund PJ, Kimura S, Gonzalez FH, Nebert DW: 1462 V mutation in the human CYP1A1 gene: Lack of correlation with either the Msp 1 1.9 kb (M2) allele or CYP1A1 inducibility in a three-generation family of East Mediterranean descent. Pharmacogenetics 4:21-26, 1994.
25. Nakachi K, Imai K, Hayashi S-I, Watanabe J, Kawajiri K: Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51:5177-5180, 1991.
26. Ichiba M, Hagmar L, Rannug A, Högstedt B, Alexandrie A-K, Carstensen U, Hemminki K: Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 15:1347-1352, 1994.
27. Sorsa M, Wilbourn J, Vainio H: Human cytogenetic damage as a predictor of cancer risk. In Vainio H, Magee PN, McGregor DB, McMichael AJ: "Mechanisms of Carcinogenesis in Risk Identification, No. 116." Lyon: International Agency for Research on Cancer, 1992, pp 543-554.